Condition: Mitochondrial Disorders · Sponsor: University Hospital, Bordeaux
The study aims at characterizing the immune dysfunctions in patients with mitochondrial diseases. This has prognostic and diagnostic interest as well as potential for the discovery of new therapeutic strategies to alleviate disease burden.
This description comes directly from the study's public registry record.
Aurélien TRIMOUILLE, MD · +335 57 82 10 49 · aurelien.trimouille@chu-bordeaux.fr
Johan Garaude, MD · johan.garaude@inserm.fr
Always discuss trial participation with your own doctor first.
| Chu Bordeaux | Bordeaux, France | Recruiting |
| Hopital Toulouse | Toulouse, France | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06213103